Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA's warning about recalled devices | A historic TAVR | Cardiologist could face life in prison for sexual assault
Tuesday, June 13, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA warns healthcare providers about recalled CPB, ECMO devices

Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.

READ MORE >
Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA warns healthcare providers about recalled CPB, ECMO devices

Share on Twitter Share on Facebook Share on Linkedin
Recall
Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.
READ MORE >

Cardiologists perform world’s first TAVR with new ultra-low profile valve

The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.

READ MORE >
Valve Medical's Xemed TAVR valve. Xemed TAVR System was developed by Valve Medical, a wholly owned subsidiary of Medinol focused on treating structural heart disease. It features a modular two-piece design and can be implanted using a standard 12 French sheath.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists perform world’s first TAVR with new ultra-low profile valve

Share on Twitter Share on Facebook Share on Linkedin
Valve Medical's Xemed TAVR valve. Xemed TAVR System was developed by Valve Medical, a wholly owned subsidiary of Medinol focused on treating structural heart disease. It features a modular two-piece design and can be implanted using a standard 12 French sheath.
The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.
READ MORE >

Cardiologist accused of date rape by 15 women could face life in prison, judge says

The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.

READ MORE >
Judge bangs gavel
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist accused of date rape by 15 women could face life in prison, judge says

Share on Twitter Share on Facebook Share on Linkedin
Judge bangs gavel
The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.
READ MORE >

Private equity-backed cardiology group acquires ‘world-class' practice with team of 23 cardiologists

This latest acquisition continues what has been a busy year for Cardiovascular Associates of America. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology group acquires ‘world-class' practice with team of 23 cardiologists

Share on Twitter Share on Facebook Share on Linkedin
This latest acquisition continues what has been a busy year for Cardiovascular Associates of America. 
READ MORE >

Featured Articles

Why health equity is important in cardiology

Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

READ MORE >
Malissa Wood, MD. explains why Mass General created a program to combat racism and health equity.
Share on Twitter Share on Facebook Share on Linkedin

Why health equity is important in cardiology

Share on Twitter Share on Facebook Share on Linkedin
Malissa Wood, MD. explains why Mass General created a program to combat racism and health equity.
Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 
READ MORE >

New Cedars-Sinai AI tool may predict cardiac events and better assess risk

Cedars-Sinai researchers are developing a deep-learning algorithm to personalize patient cardiac risk predictions in a patient-friendly, graphical report.

READ MORE >
Part of the graphical results from the Cedars-Sinai AI cardiac risk assessment tool from basic data like the patient’s age, gender, weight, heart rate, and blood pressure, and AI interpretation of cardiac imaging.
Share on Twitter Share on Facebook Share on Linkedin

New Cedars-Sinai AI tool may predict cardiac events and better assess risk

Share on Twitter Share on Facebook Share on Linkedin
Part of the graphical results from the Cedars-Sinai AI cardiac risk assessment tool from basic data like the patient’s age, gender, weight, heart rate, and blood pressure, and AI interpretation of cardiac imaging.
Cedars-Sinai researchers are developing a deep-learning algorithm to personalize patient cardiac risk predictions in a patient-friendly, graphical report.
READ MORE >

In Case You Missed It

TAVR among 90-year-old patients: An updated look at mortality, hospital costs and more

In-hospital mortality and other key outcomes have improved in recent years, but treating these older patients is still associated with certain challenges. 

READ MORE >
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
Share on Twitter Share on Facebook Share on Linkedin

TAVR among 90-year-old patients: An updated look at mortality, hospital costs and more

Share on Twitter Share on Facebook Share on Linkedin
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
In-hospital mortality and other key outcomes have improved in recent years, but treating these older patients is still associated with certain challenges. 
READ MORE >

AI organizes heart failure patients into 5 distinct groups, helping cardiologists manage care

Researchers used multiple AI models to evaluate EHR data from more than 322,000 heart failure patients. By identifying these subtypes, the group thinks clinicians could perform better risk assessments and make more informed treatment decisions. 

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

AI organizes heart failure patients into 5 distinct groups, helping cardiologists manage care

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Researchers used multiple AI models to evaluate EHR data from more than 322,000 heart failure patients. By identifying these subtypes, the group thinks clinicians could perform better risk assessments and make more informed treatment decisions. 
READ MORE >

In Other News

Prostate cancer size is frequently underestimated on imaging

Newly published data recently revealed just how common the extent of prostate cancer is underestimated based on imaging measurements. 

READ MORE >
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 
Share on Twitter Share on Facebook Share on Linkedin

Prostate cancer size is frequently underestimated on imaging

Share on Twitter Share on Facebook Share on Linkedin
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 
Newly published data recently revealed just how common the extent of prostate cancer is underestimated based on imaging measurements. 
READ MORE >

Private equity firm acquiring 'leading' teleradiology group that spans 48 states

Grovecourt Capital Partners said it hopes to fuel further expansion for Miami-based Premier Radiology Services, which was founded in 2006. 

READ MORE >
Healthcare M&A, mergers and acquisitions business deal.
Share on Twitter Share on Facebook Share on Linkedin

Private equity firm acquiring 'leading' teleradiology group that spans 48 states

Share on Twitter Share on Facebook Share on Linkedin
Healthcare M&A, mergers and acquisitions business deal.
Grovecourt Capital Partners said it hopes to fuel further expansion for Miami-based Premier Radiology Services, which was founded in 2006. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup